Roche Holding AG Virtual Event on Key Data Presented at the 2021 MDA Virtual Clinical & Scientific Conference Transcript
Ladies and gentlemen, welcome to the Roche Virtual Event on Key Data Presented at the 2021 MDA Virtual Clinical and Scientific Conference. My name is Henrick, and I'm the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)
At this time, it's my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.
Yes. Thanks a lot, Henrick. This is really kind of a routine now in these Zoom meetings with you. Welcome to our second Science Day this year. If you could kindly go to the agenda. This is -- yes, here exactly.
I'm today with Paulo Fontoura. He is the Head of Development for CNS and Rare Diseases, but in the meantime, he's also heading up the whole [NMO] department in terms of clinical lead, development lead.
And Simona, she is the counterpart basically, what the marketing end is concerned. So she is leading our therapeutic area, CNS, from a business point of view.
We
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
